Interview: Mike Bitar: Co-founder and CEO: Grupo Flor

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News

Single DMT Dose Shows Promise in Cutting TRD Symptoms

February 19th, 2026|

NEW YORK – A single intravenous dose of the psychedelic compound dimethyltryptamine (DMT), combined with psychological support, produced rapid and sustained reductions in depressive symptoms among adults with moderate-to-severe major depressive disorder, according to results ...